vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and ServisFirst Bancshares, Inc. (SFBS). Click either name above to swap in a different company.

ServisFirst Bancshares, Inc. is the larger business by last-quarter revenue ($159.0M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). ServisFirst Bancshares, Inc. runs the higher net margin — 52.2% vs -38.1%, a 90.2% gap on every dollar of revenue. Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.7%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ServisFirst Bancshares, Inc. is a U.S.-based bank holding company operating full-service banking locations primarily across the Southeastern United States. It offers a full suite of commercial banking, consumer banking, wealth management, and mortgage lending services to small and medium-sized businesses, professional clients, and individual consumers.

PRCT vs SFBS — Head-to-Head

Bigger by revenue
SFBS
SFBS
1.9× larger
SFBS
$159.0M
$83.1M
PRCT
Higher net margin
SFBS
SFBS
90.2% more per $
SFBS
52.2%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
17.7%
SFBS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
PRCT
PRCT
SFBS
SFBS
Revenue
$83.1M
$159.0M
Net Profit
$-31.6M
$83.0M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
52.2%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
31.2%
EPS (diluted)
$-0.56
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SFBS
SFBS
Q1 26
$83.1M
$159.0M
Q4 25
$76.4M
$162.2M
Q3 25
$83.3M
$136.3M
Q2 25
$79.2M
$132.1M
Q1 25
$69.2M
$131.8M
Q4 24
$68.2M
$131.9M
Q3 24
$58.4M
$123.7M
Q2 24
$53.4M
$114.8M
Net Profit
PRCT
PRCT
SFBS
SFBS
Q1 26
$-31.6M
$83.0M
Q4 25
$-29.8M
$86.4M
Q3 25
$-21.4M
$65.6M
Q2 25
$-19.6M
$61.4M
Q1 25
$-24.7M
$63.2M
Q4 24
$-18.9M
$65.2M
Q3 24
$-21.0M
$59.9M
Q2 24
$-25.6M
$52.1M
Gross Margin
PRCT
PRCT
SFBS
SFBS
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
PRCT
PRCT
SFBS
SFBS
Q1 26
-4.1%
Q4 25
-40.6%
66.3%
Q3 25
-27.8%
57.8%
Q2 25
-28.0%
58.0%
Q1 25
-39.7%
60.0%
Q4 24
-28.9%
60.2%
Q3 24
-38.4%
58.5%
Q2 24
-50.3%
58.0%
Net Margin
PRCT
PRCT
SFBS
SFBS
Q1 26
-38.1%
52.2%
Q4 25
-39.1%
59.0%
Q3 25
-25.7%
48.1%
Q2 25
-24.7%
46.5%
Q1 25
-35.8%
48.0%
Q4 24
-27.6%
52.9%
Q3 24
-35.9%
48.4%
Q2 24
-48.0%
45.4%
EPS (diluted)
PRCT
PRCT
SFBS
SFBS
Q1 26
$-0.56
$1.52
Q4 25
$-0.54
$1.58
Q3 25
$-0.38
$1.20
Q2 25
$-0.35
$1.12
Q1 25
$-0.45
$1.16
Q4 24
$-0.34
$1.19
Q3 24
$-0.40
$1.10
Q2 24
$-0.50
$0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SFBS
SFBS
Cash + ST InvestmentsLiquidity on hand
$245.6M
$1.8B
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$347.7M
$1.9B
Total Assets
$487.1M
$18.2B
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SFBS
SFBS
Q1 26
$245.6M
$1.8B
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
PRCT
PRCT
SFBS
SFBS
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SFBS
SFBS
Q1 26
$347.7M
$1.9B
Q4 25
$365.9M
$1.8B
Q3 25
$380.3M
$1.8B
Q2 25
$385.8M
$1.7B
Q1 25
$389.2M
$1.7B
Q4 24
$402.2M
$1.6B
Q3 24
$241.2M
$1.6B
Q2 24
$251.8M
$1.5B
Total Assets
PRCT
PRCT
SFBS
SFBS
Q1 26
$487.1M
$18.2B
Q4 25
$508.1M
$17.7B
Q3 25
$511.5M
$17.6B
Q2 25
$513.1M
$17.4B
Q1 25
$519.4M
$18.6B
Q4 24
$534.0M
$17.4B
Q3 24
$374.1M
$16.4B
Q2 24
$374.4M
$16.0B
Debt / Equity
PRCT
PRCT
SFBS
SFBS
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SFBS
SFBS

Net Interest Income$148.1M93%
Noninterest Income$10.8M7%

Related Comparisons